Janus Henderson Group PLC Cuts Stake in Sabra Healthcare REIT, Inc. $SBRA

Janus Henderson Group PLC lowered its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 2.6% during the 1st quarter, Holdings Channel.com reports. The firm owned 2,389,003 shares of the real estate investment trust’s stock after selling 62,702 shares during the quarter. Janus Henderson Group PLC’s holdings in Sabra Healthcare REIT were worth $45,907,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. Rothschild Investment LLC boosted its position in Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares during the period. Smartleaf Asset Management LLC increased its holdings in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the period. Strengthening Families & Communities LLC purchased a new position in shares of Sabra Healthcare REIT in the fourth quarter worth about $29,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at about $30,000. Finally, Larson Financial Group LLC lifted its stake in shares of Sabra Healthcare REIT by 42.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Stock Performance

Shares of SBRA opened at $21.17 on Monday. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The business’s 50 day moving average price is $19.77 and its 200-day moving average price is $19.92. Sabra Healthcare REIT, Inc. has a 52 week low of $17.17 and a 52 week high of $22.77. The stock has a market cap of $5.34 billion, a P/E ratio of 33.60, a P/E/G ratio of 1.64 and a beta of 0.64.

Analysts Set New Price Targets

SBRA has been the subject of several analyst reports. Robert W. Baird increased their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “neutral” rating in a report on Wednesday, July 22nd. Barclays assumed coverage on Sabra Healthcare REIT in a research report on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 price objective for the company. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Cantor Fitzgerald raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.